SelectScience InterviewsLife Sciences
Custom Phenotypic Assay Development at PhenoVista Biosciences
16 Jan 2017
Anthony Essex, PhD, Chief Scientific Officer at PhenoVista Biosciences, discusses assay development for high content screening. Learn how PhenoVista's custom iPSC neuronal and T-cell-endothelial assays are more physiologically relevant for enhanced phenotypic screening.
About the company
SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.
